Cardiovascular Disease Management - 4th Annual Symposium
Avatar

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients?

By Cardiovascular Disease Management - 4th Annual Symposium FEATURING Saibal Kar
By Cardiovascular Disease Management - 4th Annual Symposium FEATURING Saibal Kar
469 views
April 10, 2017
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
24:31
Vinod Thourani

How Do I Treat Low Gradient & Severe Aortic Stenosis?

12:45
Miami Valves

Suprasternal Direct Aortic Approach TAVR Avoid Sternotomy and Thraco…

Feat. A. Kiser
36:11
ARCH Advanced Revascularization Symposium

The UPSTREAM Management of Aortic Stenosis in the Future

Feat. M. Leon
12:41
ARCH Advanced Revascularization Symposium

CAD and Aortic Stenosis: Just Treat the Valve (Most of the Time)

Feat. M. Chung
12:45
Scripps Health: 2019 Eighth Annual Structural Heart Intervention and Imaging

Cerebral Protection for TAVR: When and Why

Feat. D. Rizik
70:52
Medtronic

Post-TAVR Coronary Access: Hands-on with the Heartroid

Feat. D. Talreja
22:06
Patrick Serruys

Valve Replacement for Pure Native Aortic Regurgitation from Alpha to…

09:48
American College of Cardiology

PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…

Feat. D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy
18:38
The Texas Heart Institute

The Latest Advances in Computational Modeling and Simulation in TAVR

Feat. Z. Krajcer
62:13
Medtronic

Hot Topics, Hotter Questions

Feat. A. Almanfi, G. Fontana, S. Baron
15:08
ARCH Advanced Revascularization Symposium

Salvaging a TAVR Disaster

Feat. J. Hermiller
04:27
Medtronic

Valve Durability Meta-Analysis

Feat. G. Attizzani
11:45
Medtronic

SURTAVI Five-Year Results

Feat. M. Reardon, N. Van Mieghem
12:26
University of Miami

How To Move Forward With Neuroprotection After PROTECTED TAVR

Feat. N. Van Mieghem
12:19
Medtronic

A Closer Look: 5-Year Data from CoreValve US Pivotal and SURTAVI Tri…

Feat. M. Reardon
29:58
San Diego Cardiovascular Interventions (SDCI) 2019

TAVR: Are We Ready for the Low Risk Patients?

Feat. R. Jauhar
11:48
New York Transcatheter Valves 2021

TAVR + CAD: Rationale & Update on COMPLETE TAVR Trial

Feat. D. Wood
18:55
New York Transcatheter Valves 2019

Valvular Heart Disease and Aortic Stenosis Management in 2020: What …

Feat. R. Nishimura
13:29
San Diego Cardiovascular Interventions 2022

Cerebral Embolic Protection During TAVR: All or Selective

Feat. G. Weisz
05:17
Boston Scientific

Cerebral Embolic Protection with SENTINEL: Technology Overview and …

Feat. H. Gada